MedTrace Logo

Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment

NCT01257243 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2019-04-17

No results posted yet for this study

Summary

The purpose of this study is evaluate if efficacy of a combination dose of oxomemazine, guaifenesin and potassium iodate is superior than guaifenesin monotherapy in acute cough treatment.

Conditions

Interventions

DRUG

Syrup of oxomemazine, guaifenesin and potassium iodate

5ml each 4 hours

DRUG

Syrup of guaifenesin

5ml each 4 hours

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Principal Investigators

  • Felipe Pinho, MD · EMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-01
Primary Completion
2013-09-30
Completion
2013-10-25

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01257243 on ClinicalTrials.gov